Familial benign hypercalcemia (FBH) and neonatal hyperparathyroidism (NHPT) are disorders of calcium homeostasis that are associated with missense mutations of the calcium-sensing receptor (CaR). We have undertaken studies to characterize such CaR mutations in FBH and NHPT and to explore methods for their more rapid detection. Nine unrelated kindreds (39 affected, 32 unaffected members) with FBH and three unrelated children with sporadic NHPT were investigated for mutations in the 3,234-bp coding region of the CaR gene by DNA sequencing. Six novel heterozygous (one nonsense and five missense) mutations were identified in six of the nine FBH kindreds, and two de novo heterozygous missense mutations and one homozygous frame-shift mutation were identified in the three children with NHPT. Our results expand the phenotypes associated with CaR mutations to include sporadic NHPT. Single-stranded conformational polymorphism analysis was found to be a sensitive and specific mutational screening method that detected > 85% of these CaR gene mutations. The single-stranded conformational polymorphism identification of CaR mutations may help in the distinction of FBH from mild primary hyperparathyroidism which can be clinically difficult. Thus, the results of our study will help to supplement the clinical evaluation of some hypercalcemic patients and to elucidate further the structure-function relationships of the CaR.
S H Pearce, D Trump, C Wooding, G M Besser, S L Chew, D B Grant, D A Heath, I A Hughes, C R Paterson, M P Whyte
Title and authors | Publication | Year |
---|---|---|
Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-in Mice Mimicking Autosomal Dominant Hypocalcemia (ADH)
B Dong, I Endo, Y Ohnishi, T Kondo, T Hasegawa, N Amizuka, H Kiyonari, G Shioi, M Abe, S Fukumoto, T Matsumoto |
Journal of Bone and Mineral Research | 2015 |
Towards tissue-specific pharmacology: insights from the calcium-sensing receptor as a paradigm for GPCR (patho)physiological bias
K Leach, AD Conigrave, PM Sexton, A Christopoulos |
Trends in Pharmacological Sciences | 2015 |
Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia
N Baran, M Braak, R Saffrich, J Woelfle, U Schmitz |
Molecular and Cellular Endocrinology | 2015 |
Polyclonality of Parathyroid Tumors in Neonatal Severe Hyperparathyroidism: POLYCLONALITY OF PARATHYROID TUMORS IN NSHPT
KR Corrado, SC Andrade, J Bellizzi, L D'Souza-Li, A Arnold |
Journal of Bone and Mineral Research | 2015 |
Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients
MM Fisher, SM Cabrera, EA Imel |
Endocrinology, diabetes & metabolism case reports | 2015 |
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype–phenotype correlations, codon bias and dominant-negative effects
FM Hannan, SA Howles, A Rogers, T Cranston, CM Gorvin, VN Babinsky, AA Reed, CE Thakker, D Bockenhauer, RS Brown, JM Connell, J Cook, K Darzy, S Ehtisham, U Graham, T Hulse, SJ Hunter, L Izatt, D Kumar, MJ McKenna, JA McKnight, PJ Morrison, MZ Mughal, D O'Halloran, SH Pearce, ME Porteous, M Rahman, T Richardson, R Robinson, I Scheers, H Siddique, WG Hoff, T Wang, MP Whyte, MA Nesbit, RV Thakker |
Human Molecular Genetics | 2015 |
The calcium-sensing receptor: And its involvement in parathyroid pathology
RV Thakker |
Annales d'Endocrinologie | 2015 |
Hyperparathyroidism and the general paediatrician
T Cheetham, R Bliss |
Archives of disease in childhood | 2015 |
Pediatric Nephrology
ED Avner, WE Harmon, P Niaudet, N Yoshikawa, F Emma, S Goldstein |
Pediatric Nephrology | 2015 |